Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 8, 2008, Pages 700-708

  Ono, E ^a   Nunes dos Santos, A M ^a   de Menezes Succi, R C ^a   Machado, D M ^a   de Angelis, D S A ^b   Salomao R ^a   Kallas E G ^a   de Moraes Pinto, M Isabel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Highly active antiretroviral therapy; HIV 1; Immunological simulation; Immunophenotyping; Neonates of HIV infected mothers

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; EFAVIRENZ; INTERLEUKIN 7; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DELIVERY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MOTHER; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; UMBILICAL CORD; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 52949089339     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008000800011     Document Type: Article

References (39)

1. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005; 308: 1582-1583.
2. UNAIDS. 2004 Report on the global AIDS epidemic: 4th global report. UNAIDS/04.16E, Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland. http://www.unaids.org/bangkok2004/report.html
3. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin infect Dis 2005; 40: 458-465.
4. Clerici M, Sareseila M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96: 3866-3871.
5. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sorensen TU, Dreves AM, et el. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CE4 counts. Blood 2001; 98: 398-404.
6. Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13: 246-252.
7. Harari A, Rizzardi GP, Ellefsen K, Ciuffreda D, Champagne P, Bart PA, et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002; 100: 1381-1387.
8. Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003; 101: 4260-4266.
9. Joseph KS, Kramer MS, Marcoux S, Ohlsson A, Wen SW, Allen A, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998; 339: 1434-1439.
10. Silva AA, Lamy-Filho F, Alves MT, Coimbra LC, Bettiol H, Barbieri MA. Risk factors for low birthweight in north-east Brazil: the role of caesarean section. Paediatr Perinat Epidemiol 2001; 15: 257-264.
11. Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, et al. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Pediatr Infect Dis J 2006; 25: 325-332.
12. European Collaborative Study. levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS 2004; 18: 2009-2017.
13. Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 2005; 94: 1571-1577.
14. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis 2006; 194; 1089-1097.
15. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomao R, et al. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Cytometry B Clin Cytom 2007; 72: 14-21.
16. Abbas AK, Lichtman AH. Effector mechanisms of cell-mediated immunity. In: Abbas AK, Lichtman AH, Pober JS (Editors), Cellular and molecular immunology. Philadelphia: Elsevier; 2008. p 298-317.
17. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15: 575-581.
18. Aldhous MC, Watret KC, Mok JY, Bird AG, Froebel KS. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol 1904; 97: 61-67.
19. De Maria A, Cirillo C,. Moretta L. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994; 170: 1296-1299.
20. McFarland EJ, Harding PA, Luckey D, Conway B, Young RK, Kuritzkes DR. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. J Infect Dis 1994; 170: 766-774.
21. Luzuriaga K, Holmes D, Hereema A, Wong J, Panicali DL, Sullivan JL. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol 1995; 154: 433-443.
22. Levy JA, Hsueh F, Blackbourn DJ, Wara D, Weintrub PS. CD8 cell noncytotoxic antiviral actvity in human immunodeficiency virus-infected and -uninfected children. J Infect Dis 1998; 177: 470-472.
23. Wasik TJ, Bratosiewicz J, Wierzbicki A, Whiteman VE, Rutstein RR, Starr SE, et al. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 1999; 162: 4355-4364.
24. Kuhn L, Coutsoudis A, Moodley D, Trabattoni D, Mngqundaniso N, Shearer GM, et al. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission. AIDS 2001; 15: 1-9.
25. Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 2006; 1: e102.
26. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165: 1012-1019.
27. Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994; 271: 42-46.
28. Fowke KR, Kaul R, Rosenthal KL, Oyugi J, Kimani J, Rutherford WJ, et al. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol 2000; 78: 586-595.
29. Alimonti JB, Koesters SA, Kimani J, Matu L, Wachihi C, Plummer FA, et al. CD4+ T cell responses in HIV-exposed seronegetive women are qualitatively distinct from those in HIV-infected women. J Infect Dis 2005; 191: 20-24.
30. Schenal M, Lo CS, Fasano F, Vichi F, Saresella M, Pierotti P, et al. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 2005; 19: 653-661.
31. Montoya CJ, Velilla PA, Chougnet C, Landay AL, Rugeles MT. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol 2006; 120: 138-146.
32. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pedersen BK. Defective natural immunity: an early manifestation of human immunedeficiency virus infection. J Exp Med 1995; 182: 789-799.
33. Alter G, Malenfant JM, Delabre RM, Burgett NC, Yu XG, Lichterfeld M, et al. Increased natural killer cell activity in viremic HIV-1 infection. J Immunol 2004; 173: 5305-5311.
34. Resino S, Galan I, Perez A, Leon JA, Seoane E, Gurbindo D, et al. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy. Clin Exp Immunol 2004; 137: 570-577.
35. Gonzalez I, Gil L, Molina R, Gonzalez A, Toledo ME, Diaz-Jidy M, et al. Immunological characteristic of children vertically infected with HIV: a case-control study. Rev Invest Clin 2005; 57: 498-504.
36. Lambert JS, Moye J Jr, Plaeger SF, Stiehm ER, Bethel J, Mofenson LM, et al. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol 2005; 12: 622-631.
37. Lima M, De Menezes Succi RC, Nunes Dos Santos AM, Weckx LY, de Moraes-Pinto MI. Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies. Pediatr Infect Dis J 2004; 23: 604-607.
38. Resino S, Seoane E, Gutierrez MD, Leon JA, Munoz-Fernandez MA. CD4(+) T-cell immunedeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42: 269-276.
39. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, Kitahata M, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296: 1498-1506.